[方法]将符合CCMD-3诊断标准出院的精神分裂症80例病人随机分为研究组和对照组,采用简明精神病量表(BRPS)、社会功能缺陷筛选量表(SDSS)和WHO生存质量测定简表对两组病人进行18个月的干预评估。
基于16个网页-相关网页
采用简明精神病量表(BPRS)、阳性和阴性症状量表(PANSS)进行评价。
Brief psychiatric Rating Scale (BPRS) and Positive and Negative Syndrome Scale (PANSS) were used to assess the effects.
采用日常生活能力量表(ADL)对两组患者生活能力情况进行评定,并用简明精神病评定量表(BPRS)观察两组患者的预后。
With activities of daily living (ADL), capable of living conditions of the two groups were assessed with the Brief Psychiatric Rating Scale (BPRS) the prognosis of patients were observed.
采用异常不自主运动量表(AIMS)和简明精神病评定量表(BPRS)及副反应量表(TESS)在治疗前及治疗后1、2、4、6周末分别评定疗效及不良反应。
The efficacy and safety were assessed with AIMS, BPRS and TESS at the end of week 1,2,4 and 6.
应用推荐